T1	Participants 11 29	paclitaxel-induced
T2	Participants 233 251	paclitaxel-induced
T3	Participants 282 357	Thirty-two patients undergoing six courses of paclitaxel-based chemotherapy
T4	Participants 1365 1385	patients with cancer
